Lipigon Pharmaceuticals (Sweden) Today
| LPGO Stock | SEK 0.17 0.01 6.25% |
Performance0 of 100
| Odds Of DistressOver 84
|
Lipigon Pharmaceuticals is selling for under 0.17 as of the 28th of November 2024; that is 6.25 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.16. Lipigon Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Lipigon Pharmaceuticals AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Lipigon Pharmaceuticals AB develops drugs for lipid related diseases in Sweden. Lipigon Pharmaceuticals AB was founded in 2010 and is based in Ume, Sweden. Lipigon Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden. The company has 20.24 M outstanding shares. More on Lipigon Pharmaceuticals AB
Moving together with Lipigon Stock
| 0.75 | CAMX | Camurus AB | PairCorr |
| 0.83 | HNSA | Hansa Biopharma AB | PairCorr |
| 0.84 | NANOFS | Nanoform Finland Plc | PairCorr |
Moving against Lipigon Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lipigon Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lipigon Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lipigon Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Lipigon Pharmaceuticals AB (LPGO) is traded on Stockholm Exchange in Sweden and employs 7 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lipigon Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Lipigon Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lipigon Pharmaceuticals operates under Healthcare sector and is part of Biotechnology industry. The entity has 20.24 M outstanding shares.
Lipigon Pharmaceuticals AB has accumulated about 58.95 M in cash with (35.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Lipigon Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationLipigon Pharmaceuticals maintains a total of 20.24 Million outstanding shares. Lipigon Pharmaceuticals AB holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lipigon Ownership Details
Lipigon Pharmaceuticals Risk Profiles
Although Lipigon Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Lipigon Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.08 | |||
| Standard Deviation | 7.34 | |||
| Variance | 53.88 | |||
| Risk Adjusted Performance | (0.06) |
Lipigon Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lipigon Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Lipigon Pharmaceuticals Corporate Management
Elected by the shareholders, the Lipigon Pharmaceuticals' board of directors comprises two types of representatives: Lipigon Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lipigon. The board's role is to monitor Lipigon Pharmaceuticals' management team and ensure that shareholders' interests are well served. Lipigon Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lipigon Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lars hman | Bus Chairman | Profile | |
| Stefan Nilsson | CoFounder CEO | Profile | |
| Michael Owens | Chief Officer | Profile | |
| Pr Olivecrona | Cofounder Member | Profile |
Additional Tools for Lipigon Stock Analysis
When running Lipigon Pharmaceuticals' price analysis, check to measure Lipigon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipigon Pharmaceuticals is operating at the current time. Most of Lipigon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lipigon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipigon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lipigon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.